IBM
58
-2
NDAQ
62
2
CSCO
67
4
NVDA
56
-4
PNC
64
4
RHI
59
2
TSCO
49
5
PGR
65
2
KLAC
47
4
HON
67
2
EMN
60
4
CA
38
6
LYB
39
2
F
58
11
DOW
44
10
VTR
47
-7
URI
65
5
BSX
67
-3
BF.B
33
2
ROST
63
12
IBM
58
-2
NDAQ
62
2
CSCO
67
4
NVDA
56
-4
PNC
64
4
RHI
59
2
TSCO
49
5
PGR
65
2
KLAC
47
4
HON
67
2
EMN
60
4
CA
38
6
LYB
39
2
F
58
11
DOW
44
10
VTR
47
-7
URI
65
5
BSX
67
-3
BF.B
33
2
ROST
63
12
Financhill
Back

Kairos Pharma Vs. Zenas BioPharma Industry Stock Comparison

Sell
14

KAPA
Kairos Pharma

Last Price:
1.61
Seasonality Move:
--
Sell
29

ZBIO
Zenas BioPharma

Last Price:
11.98
Seasonality Move:
1.54%
Sell
14
Kairos Pharma (KAPA) is a Sell

Is Kairos Pharma a Buy, Sell or Hold?

  • The current Kairos Pharma [KAPA] share price is $1.60. The Score for KAPA is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
  • KAPA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
29
Zenas BioPharma (ZBIO) is a Sell

Is Zenas BioPharma a Buy, Sell or Hold?

  • The current Zenas BioPharma [ZBIO] share price is $12.00. The Score for ZBIO is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • ZBIO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KAPA Stock Price Chart

What is Kairos Pharma's stock price today?

  • The Kairos Pharma share price today is $1.60
    The current trend is relatively stagnant and KAPA is experiencing slight selling pressure.

ZBIO Stock Price Chart

What is Zenas BioPharma's stock price today?

  • The Zenas BioPharma share price today is $12.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ZBIO is experiencing buying pressure, which is a positive indicator for future bullish movement.

KAPA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.11 Buy
Relative Strength Index (14 RSI): 49.3 Sell
Chaikin Money Flow: -44456 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.27 - 1.75) Buy
Bollinger Bands (100): ( - ) Buy

ZBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.66 Sell
Relative Strength Index (14 RSI): 28.62 Sell
Chaikin Money Flow: 588416 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.71 - 23.27) Sell
Bollinger Bands (100): (8.72 - 18.66) Sell

KAPA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.69 Sell
20-day SMA: 1.52 Buy
50-day SMA: 0 Buy
200-day SMA: 0 Buy
8-day EMA: 1.59 Buy
20-day EMA: 1.53 Buy
50-day EMA: 1.21 Buy
200-day EMA: 0.49 Buy

ZBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 14.94 Sell
20-day SMA: 18.48 Sell
50-day SMA: 17.37 Sell
200-day SMA: 13.21 Sell
8-day EMA: 14.43 Sell
20-day EMA: 17.05 Sell
50-day EMA: 16.9 Sell
200-day EMA: 14.22 Sell

Kairos Pharma Earnings Growth & KAPA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.13 per share.

Zenas BioPharma Earnings Growth & ZBIO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $2.84 per share.

Kairos Pharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Zenas BioPharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):